Form 4: Clorox Director Matthew J. Shattock Reports Acquisition of Deferred Stock Units

Director Matthew J. Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Summary

• Matthew J. Shattock, a director of Clorox, reported acquiring deferred stock units.
• The transactions occurred on February 14, 2025, and March 31, 2025.
• The acquisitions were made through dividend reinvestment and in lieu of quarterly director's fees.
• A total of 127.3104 units were acquired on February 14, 2025, and 348.0475 units on March 31, 2025.
• The deferred stock units will be settled in Clorox stock upon the director's retirement or termination of service.
• Following the reported transactions, Shattock beneficially owns 15,911.2195 deferred stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's acquisition of deferred stock units indicates confidence in the company's future, and the structure of the compensation aligns interests with shareholders. There are no explicitly negative aspects in the filing.

Positives

• The acquisition of deferred stock units aligns the director's interests with those of the shareholders.
• Dividend reinvestment indicates confidence in the company's future performance.
• Receipt of stock units in lieu of fees demonstrates a commitment to the company's long-term success.

Future Outlook

The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or other termination of service, indicating a long-term stake in the company's performance.

Industry Context

Directors often receive stock-based compensation to align their interests with shareholders, a common practice in publicly traded companies.

Stakeholder Impact

• The acquisition of deferred stock units aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
• Employees may view this as a positive sign of leadership commitment.

Key Dates

Keywords

Clorox, Director, Deferred Stock Units, Dividend Reinvestment, Form 4, SEC Filing, Matthew J. Shattock